These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 19413182)
1. Non-steroidal anti-inflammatory drugs and the risk of cardiovascular diseases: are we going to see the revival of cyclooxygenase-2 selective inhibitors? Głuszko P; Bielińska A Pol Arch Med Wewn; 2009 Apr; 119(4):231-5. PubMed ID: 19413182 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis. Wang X; Tian HJ; Yang HK; Wanyan P; Peng YJ Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):876-80. PubMed ID: 21900785 [TBL] [Abstract][Full Text] [Related]
4. Review of the cardiovascular safety of COXIBs compared to NSAIDS. Moodley I Cardiovasc J Afr; 2008; 19(2):102-7. PubMed ID: 18516356 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Cannon CP; Curtis SP; FitzGerald GA; Krum H; Kaur A; Bolognese JA; Reicin AS; Bombardier C; Weinblatt ME; van der Heijde D; Erdmann E; Laine L; Lancet; 2006 Nov; 368(9549):1771-81. PubMed ID: 17113426 [TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular risk of non-steroidal anti-inflammatory drugs]. Hermann M Praxis (Bern 1994); 2012 Oct; 101(20):1309-14. PubMed ID: 23032496 [TBL] [Abstract][Full Text] [Related]
8. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events. Scheiman JM; Hindley CE Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis. Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070 [TBL] [Abstract][Full Text] [Related]
10. How to advise aspirin use in patients who need NSAIDs. Sopena F; Lanas A Curr Pharm Des; 2007; 13(22):2248-60. PubMed ID: 17691998 [TBL] [Abstract][Full Text] [Related]
12. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. Scheiman JM; Fendrick AM Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S23-9. PubMed ID: 16168078 [TBL] [Abstract][Full Text] [Related]
13. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs. Scheiman JM Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260 [TBL] [Abstract][Full Text] [Related]
14. The NSAID dilemma: managing osteoarthritis in high-risk patients. Roth SH; Anderson S Phys Sportsmed; 2011 Sep; 39(3):62-74. PubMed ID: 22030942 [TBL] [Abstract][Full Text] [Related]
15. COX-2 inhibitors: a CLASS act or Just VIGORously promoted. Malhotra S; Shafiq N; Pandhi P MedGenMed; 2004 Mar; 6(1):6. PubMed ID: 15208519 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen. De Vecchis R; Baldi C; Di Biase G; Ariano C; Cioppa C; Giasi A; Valente L; Cantatrione S Minerva Cardioangiol; 2014 Dec; 62(6):437-48. PubMed ID: 25029569 [TBL] [Abstract][Full Text] [Related]
17. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs. Hur C; Chan AT; Tramontano AC; Gazelle GS Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709 [TBL] [Abstract][Full Text] [Related]
18. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. Kearney PM; Baigent C; Godwin J; Halls H; Emberson JR; Patrono C BMJ; 2006 Jun; 332(7553):1302-8. PubMed ID: 16740558 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Hermann M; Ruschitzka F Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448 [TBL] [Abstract][Full Text] [Related]
20. [Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?]. Valat JP; Deray G; Héloire F Presse Med; 2006 Sep; 35 Suppl 1():25-34. PubMed ID: 17870550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]